Trinity Biotech (TRIB) Deferred Taxes (2021 - 2024)

Trinity Biotech (TRIB) has reported Deferred Taxes for 4 consecutive years, with $585000.0 the latest figure, recorded in Q4 2024.

• Quarterly Deferred Taxes rose 19600.0% year-over-year to $585000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $565971.0 (up 146.85% YoY) and the FY2024 annual result came in at $486000.0, up 923.73% from the prior year.
• Deferred Taxes grew to $585000.0 in Q4 2024 per TRIB's latest filing, from -$3000.0 in the prior quarter.
• Over the last five years, Deferred Taxes for TRIB reached as high as $585000.0 in Q4 2024 and fell as low as -$1.2 million in Q4 2021.
• A 4-year average of -$103729.0 and a median of -$1514.5 in 2022 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2022 — Deferred Taxes sank 104.43% — and 2024, when it jumped 19600.0%.
• Year by year, Deferred Taxes stood at -$1.2 million in 2021, then jumped by 98.65% to -$16000.0 in 2022, then jumped by 81.25% to -$3000.0 in 2023, then soared by 19600.0% to $585000.0 in 2024.
• According to Business Quant data, Deferred Taxes over the past three periods registered $585000.0, -$3000.0, and -$16000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.